Baloxavir Marboxil(CAS: 1985606-14-1)

Baloxavir Marboxil is a crystalline compound with a molecular weight of approximately 629.6 g/mol. It has a pKa of about 6.5 and solubility in water of 0.5 mg/mL. The compound is stable in acidic conditions but can degrade in basic media. It is reactive towards nucleophilic attack and exhibits good lipophilicity, making it suitable for oral administration.

Baloxavir Marboxil is synthesized through a multi-step路线，包括酰胺化、酯交换和还原反应。关键步骤涉及使用二异丙基乙胺作为催化剂，在无水无氧条件下进行反应。总收率约为80%，产物通过HPLC和NMR进行纯度和结构确认。

Baloxavir Marboxil is primarily used in the pharmaceutical industry. It is an antiviral drug used for the treatment of influenza. Additionally, it has potential applications in research for developing new antiviral drugs and therapies.

When handling Baloxavir Marboxil, wear appropriate personal protective equipment (PPE), including gloves, laboratory coat, and safety goggles. Work in a well-ventilated area or a fume hood to avoid inhalation. Store the compound in a cool, dry place away from direct sunlight. In case of spill, clean up immediately using appropriate absorbent materials and follow standard safety protocols. Always refer to the Material Safety Data Sheet (MSDS) for specific handling instructions.